HARROW, INC. — Director's Dealing 2013

Jul 1, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Imprimis Pharmaceuticals, Inc. (IMMY)
CIK: 0001360214
Period of Report: 2013-06-27

Reporting Person: Kammer Robert J (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-06-27	COMMON STOCK	A	6865	—	Acquired	898356	Direct
2013-06-28	COMMON STOCK	A	33333	—	Acquired	931689	Direct

Footnotes

F1: Award of Restricted Stock Units vests in full on the thirteen month anniversary of the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service.

F2: Common Stock issued to the Reporting Person as compensation for consulting services under an advisory agreement entered into on April 1, 2012.